Overview


According to FutureWise analysis the market for Aquaculture Vaccines in 2023 is US$ 0.41 billion, and is expected to reach US$ 0.79 billion by 2031 at a CAGR of 8.70%.

Aquaculture vaccines are specialized vaccines designed to protect aquatic organisms, especially fish and shellfish, from various diseases. These vaccines play a crucial role in the aquaculture industry, which involves the cultivation of aquatic organisms for human consumption. In aquaculture, the close proximity of fish and shellfish in farms or hatcheries can create an environment conducive to the spread of diseases. Pathogens like bacteria, viruses, and parasites can quickly proliferate and lead to outbreaks that can have devastating effects on aquaculture operations. Vaccination is an effective way to prevent or lower the severity of these diseases. Aquaculture vaccines work by stimulating the immune system of the aquatic organism, usually a fish or shrimp, to produce specific antibodies against the targeted pathogen. These antibodies provide protection when the organism is later exposed to the actual disease-causing agent in the environment.

There are several types of aquaculture vaccines, including inactivated vaccines, live attenuated vaccines, subunit vaccines, DNA vaccines, and recombinant vaccines. Inactivated vaccines are made from pathogens that have been killed or inactivated, so they can't cause disease. They're often mixed with adjuvants (substances that enhance the immune response) to make them more effective. Live attenuated vaccines use live pathogens that have been weakened or attenuated so they can stimulate an immune response without causing disease. They are usually administered orally or through immersion. Moreover, subunit vaccines contain only specific parts of the pathogen (such as proteins or genetic material) that trigger an immune response. They are considered safe because they do not contain live or inactivated pathogens. Also, DNA vaccines involve inserting genetic material from the pathogen into the organism's cells. The cells then produce the pathogen's proteins, stimulating an immune response.

FutureWise Market Research has published a report that provides an insightful analysis aquaculture vaccines market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts aquaculture vaccines market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Zoetis
  • Phibro Animal Health Corporation
  • Elanco
  • Merck & Co., Inc.
  • KBNP
  • CAVAC
  • Kyoto Biken Laboratories, Inc.
  • Nisseiken Co., Ltd.
  • Vaxxinova International B.V.
  • HIPRA

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing demand for aquatic animal-derived food products is anticipated to bolster the market growth. This demand surge has emphasized the crucial role of efficient aquaculture practices in meeting this rising need. Unlike traditional fishing, which is constrained by finite wild fish stocks and often plagued by overfishing concerns, aquaculture offers a controlled and sustainable means of seafood production. By cultivating fish and other aquatic organisms in controlled environments, aquaculture not only alleviates pressure on natural fish populations but also enables producers to meet the escalating demand for seafood in a more controlled, reliable, and environmentally conscious manner. Consequently, as the global population continues to grow, the imperative for efficient and sustainable aquaculture practices stands out as a crucial driver in shaping the future of the aquaculture industry. Moreover, in emerging markets where aquaculture practices are still evolving, notable growth potential is present for aquaculture vaccines. These regions often wrestle with developing industry practices and may not have established robust disease management protocols. This presents an opportunity market for vaccine manufacturers to provide essential solutions tailored to the unique challenges faced by these developing aquaculture sectors. Also, the ability to offer customized vaccines that address specific regional or species-specific disease threats is a distinctive opportunity. Niche players in the market, possessing specialized knowledge and capabilities, may seize this chance to develop customized vaccines that effectively combat prevalent diseases in specific aquaculture contexts. By doing so, they not only cater to the specific needs of these markets but also gain a competitive edge by offering targeted, high-impact solutions that facilitate the overall health and sustainability of the aquaculture industry. However, establishing a comprehensive vaccination program in aquaculture demands a substantial initial capital expenditure, presenting a formidable obstacle for smaller or financially constrained operations within the industry. The costs associated with research, development, production, and distribution of vaccines might be particularly burdensome for enterprises lacking robust financial resources. Furthermore, the intricate nature of developing vaccines tailored to the unique physiology of aquatic species poses another significant restraint. This complexity extends the timeline for bringing new vaccines to market, requiring meticulous research, testing, and refinement. Consequently, this intricate process may impede the swift introduction of innovative vaccines, potentially leaving aquaculture operations vulnerable to prevalent diseases for a longer period, further hindering market growth.

By Vaccine Type

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

By Route Of Administration

  • Oral
  • Injected 
  • Immersion and Spray

By Application

  • Bacterial
  • Viral
  • Parasitic

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Europe registered highest share in the market in 2022. Owing to the high aquaculture production, growing demand for aquatic animal-derived food products, high prevalence of infectious diseases in the aquaculture field, and an increase in aquaculture farming are the factors expected to drive the market expansion. Furthermore, the presence of key players investing in product launches, collaborative agreements, geographical expansion, and acquisitions further propel the target market in the region over the forecast period. For instance, in April of 2021, CIBA introduced Nodavac-R, a recombinant viral nervous necrosis (VNN) vaccine administered via injection. This vaccine is highly effective in preventing VNN caused by RGNNV in fingerlings and inhibiting vertical transmission in brooders. It is suitable for a wide range of fish species, such as milkfish, grey mullet, and mangrove red snapper, all of which are susceptible to VNN. Also, CIBA is in the process of creating an oral vaccine that can be delivered through both feed and immersion methods.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Aquaculture Vaccines Market By Vaccine Type, By Route of Administration, By Application, and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  Aquaculture Vaccines Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aquaculture Vaccines Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aquaculture Vaccines Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aquaculture Vaccines Market, By Vaccine Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Attenuated Live Vaccines
        2. Inactivated Vaccines
        3. Subunit Vaccines
        4. DNA Vaccines
        5. Recombinant Vaccines

  • 8.  Aquaculture Vaccines Market, By Route Of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Injected
        3. Immersion and Spray

  • 9.  Aquaculture Vaccines Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Bacterial
        2. Viral
        3. Parasitic

  • 10.   North America Aquaculture Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Aquaculture Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Aquaculture Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Aquaculture Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Aquaculture Vaccines Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Zoetis
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Phibro Animal Health Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Elanco
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. MerckCo., Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. KBNP
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. CAVAC
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Kyoto Biken Laboratories, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Nisseiken Co., Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Vaxxinova International B.V.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. HIPRA
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Aquaculture Healthcare Market

Read More

Bacterial Diagnostics in Aquaculture Market

Read More
Partner

Our Clients